Medication info
Pitavastatin Tablet (Pitavastatin Calcium Hydrate)

Pitavastatin Tablet (Pitavastatin Calcium Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium Hydrate›2mg / 1 tablet
Manufacturer / importer
Austin Pharmaceutical Co., Ltd.
Appearance
Light yellowish-red round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201103569 · Approved 2011.05.30 · Insurance code 654304480

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. The usual initial dose for adults is 1~2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is inadequate, the dose may be increased to a maximum of 4 mg daily. Depending on the LDL cholesterol level, treatment goal, and patient response, the dose should be appropriately adjusted at intervals of 4 weeks or longer. The therapeutic effect of this drug is maintained with continued administration.

Ingredients

Manufacturer
Austin Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated apolipoprotein B
  • elevated triglycerides
View approved original text

This medication helps lower total cholesterol, LDL cholesterol, apolipoprotein B, and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia when used alongside a dietary regimen, and increases HDL cholesterol levels. It contributes to improving the blood lipid profile and reducing the risk of cardiovascular disease. Therefore, it is effectively used in the management of dyslipidemia.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. The usual initial dose for adults is 1~2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is inadequate, the dose may be increased to a maximum of 4 mg daily. Depending on the LDL cholesterol level, treatment goal, and patient response, the dose should be appropriately adjusted at intervals of 4 weeks or longer. The therapeutic effect of this drug is maintained with continued administration.

Precautions

This medication should not be used in certain patients. First of all, patients who have had allergic reactions to this medication, patients with very poor liver function, patients with active liver disease, and patients with biliary obstruction should not take this medication. Additionally, patients taking cyclosporine, patients with myopathy, women who are pregnant or may become pregnant, breastfeeding women, and children should not use this medication. Patients with lactose intolerance or genetic metabolic disorders should also not take this medication. This medication should be used with caution in some patients. Patients with impaired kidney function, liver dysfunction, excessive alcohol consumption, hypothyroidism, and the elderly should be especially cautious when taking this medication. Furthermore, patients who are taking certain medications along with this treatment may have an increased risk of muscle damage, so they must consult with a physician. Various adverse reactions may occur with this medication. Muscle pain or weakness, liver dysfunction, skin rashes, dyspepsia, and blood abnormalities have been reported, and in rare cases, serious side effects such as severe muscle damage, kidney problems, or interstitial lung disease may also occur. If these symptoms appear, immediate consultation with a doctor is necessary. This medication is used for the treatment of dyslipidemia, and prior to administration, it is crucial to check blood cholesterol levels and combine it with diet and exercise therapy. Regular blood tests should be conducted during administration to monitor liver function and muscle condition, and if abnormal findings are detected, drug use may be discontinued. This medication can interact with certain medications, so it is essential to inform the physician or pharmacist if you are taking other medications. Especially when taken with cyclosporine, fibrate drugs, nicotinic acid, or erythromycin, the risk of serious side effects may increase, necessitating caution. Elderly patients are at higher risk of side effects due to decreased body function, so dose adjustment and careful monitoring are required when taking this medication. Women who are pregnant or breastfeeding should not take this medication, and women who may become pregnant must confirm their pregnancy before taking it. In the case of children, the safety and efficacy of this medication have not been sufficiently established, so its use is not recommended. This medication should be stored out of reach of children, and it should be kept in its original container to prevent misuse or deterioration in quality.

Side effects

  • abdominal pain
  • rash
  • malaise
  • paralysis
  • itching
  • muscle pain
  • weakness
  • elevated CPK levels
  • increased myoglobin in blood and urine
  • acute renal failure
Show 91 more
  • liver dysfunction
  • jaundice
  • thrombocytopenia
  • hives
  • erythema
  • angioedema
  • elevated bilirubin
  • increased cholinesterase
  • elevated AST
  • elevated ALT
  • elevated γ-GT
  • elevated ALP
  • elevated LDH
  • rigidity
  • drowsiness
  • insomnia
  • headache
  • heaviness in the head
  • dizziness
  • thirst
  • dyspepsia
  • abdominal bloating
  • constipation
  • stomatitis
  • vomiting
  • loss of appetite
  • glossitis
  • nausea
  • gastric discomfort
  • diarrhea
  • granulocytopenia
  • leukopenia
  • eosinophilia
  • leukocytosis
  • elevated globulin
  • positive Coombs test
  • anemia
  • polyuria
  • elevated BUN
  • elevated serum creatinine
  • decreased aldosterone
  • elevated aldosterone
  • increased adrenocorticotropic hormone
  • elevated cortisol
  • decreased testosterone
  • muscle cramps
  • muscle pain
  • fatigue
  • palpitations
  • fatigue
  • dermal pain
  • burning sensation
  • joint pain
  • edema
  • blurred vision
  • photophobia
  • hearing loss
  • hematuria
  • elevated uric acid levels
  • increased serum potassium and phosphorus
  • dysgeusia
  • malaise
  • positive antinuclear antibodies
  • sleep disorders
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes
  • immune-mediated necrotizing myopathy
  • myasthenia gravis
  • ocular muscle weakness
  • facial edema
  • arm edema
  • hypersensitivity
  • headache
  • dizziness
  • paresthesia
  • insomnia
  • loss of appetite
  • elevated blood pressure
  • chest discomfort
  • weakness
  • dyspepsia
  • thirst
  • nausea
  • thrombocytopenia
  • increased serum creatinine
  • elevated BUN
  • paresthesia
  • chest discomfort

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in a special container that prevents light exposure. Additionally, it is essential to store it at room temperature between 1 and 30 degrees Celsius to maintain its effectiveness.

Appearance and packaging

Appearance

Light yellowish-red round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.